ARTICLE | Distillery Therapeutics
Cancer; infectious disease
July 10, 2018 9:38 PM UTC
In vitro, cell culture and mouse studies identified an aminopyrimidine-based dual JAK-2/HDAC6 inhibitor that could help treat AML and Candida albicans infection. Chemical synthesis of aminopyrimidine ...
BCIQ Company Profiles